A significant portion of initial submissions result in rejection by regulators - CBI redaction content for initial submission packages. CCI/CBI continues to be a critical component to disclosure submissions with regulators, yet, the tendency to over redact remains. This webinar will review internal business considerations, the need for strong collaboration between Disclosure, Legal and Clinical teams and balancing the needs of regulators.

Register Here: https://rlsciences.zoom.us/webinar/register

Date: Thursday, June 23rd, 2022

Time: 10am EST

Working with rare disease populations requires compliance strategies be thought through carefully in advance. Small populations, like those found in rare and ultra-rare disease populations can increase the likelihood of patient re-identification if advanced methods are not applied. This webinar session will focus on learnings and best practices to apply when working with rare disease trials and populations.

Register Here: https://rlsciences.zoom.us/webinar/register

Date: Thursday, April 28th

Time: 10:00am EST